Skip to main content Accessibility help
×
Home

Role of Matching in Case-Control Studies of Antimicrobial Resistance

  • Elizabeth Cerceo (a1), Ebbing Lautenbach (a1) (a2) (a3) (a4), Darren R. Linkin (a2) (a4), Warren B. Bilker (a2) (a3) (a4) and Ingi Lee (a1) (a3) (a4)...

Abstract

Of 57 case-control studies of antimicrobial resistance, matching was used in 23 (40%). Matched variables differed substantially across studies. Of these 23 matched case-control studies, 12 (52%) justified the use of matching, and 9 (39%) noted the strengths or limitations of this approach. Analysis that accounted for matching was performed in only 52% of the case-control studies.

Copyright

Corresponding author

Division of Infectious Diseases, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3rd Floor, Silverstein Building, Suite E, Philadelphia, PA 19104) ingi.lee@uphs.upenn.edu)

References

Hide All
1.Straelens, M. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ 1998;317:652654.
2.Gold, H, Moellering, R. Antimicrobial-drug resistance. N Engl J Med 1996;335:14451453.
3.Hennekens, CH, Buring, JE. Epidemiology in Medicine. Philadelphia, PA: Lippincott, Williams & Wilkins; 1987.
4.Woodward, M. Epidemiology: Study Design and Data Analysis. Boca Raton, FL: Chapman and Hall/CRC Press; 2005.
5.Malvy, D, Treilhaud, M, Bouee, S, et al. A retrospective, case-control study of acyclovir resistance in herpes simplex virus. Clin Infect Dis 2005;41:320326.
6.Lee, NE, Taylor, MM, Bancroft, E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men (published correction appears in Clin Infect Dis 2005;41:135). Clin Infect Dis 2005;40:15291534.
7.Falagas, M, Mourtzoukou, E, Ntziora, F, Peppas, G, Rafailidis, P. Matching criteria in case-control studies on postoperative infections. J Hosp Infect 2008;69:101113.
8.Soriano, A, Martinez, JA, Mensa, J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000;30:368373.
9.Vasquez, J, Walker, E, Franzus, B, Overbay, B, Reagan, D, Sarubbi, F. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a veterans' affairs hospital. Infect Control Hosp Epidemiol 2000;21:459464.
10.Byers, K, Anglim, A, Anneski, C, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140147.
11.Ho, P, Tse, W, Tsang, K, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001;32:701707.
12.Lautenbach, E, Patel, J, Bilker, W, Edelstein, P, Fishman, N. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:11621171.
13.Moroney, J, Fiore, A, Harrison, L, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33:797805.
14.Tacconelli, E, Tumbarello, M, de Gaetano Donati, K, et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis 2001;33:16281635.
15.Harris, AD, Karchmer, TB, Carmeli, Y, Samore, MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:10551061.
16.Carmeli, Y, Eliopoulos, G, Samore, M. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8:802807.
17.Cetinkaya, Y, Falk, P, Mayhall, C. Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus fae-cium in hospitalized patients. Clin Infect Dis 2002;35:935942.
18.Lodise, T, McKinnon, P, Tam, V, Rybak, M. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922929.
19.Lonks, J, Garau, J, Gomez, L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35:556564.
20.Hirakata, Y, Yamaguchi, T, Nakano, M, et al. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003;37:2632.
21.Jernigan, J, Pullen, A, Flowers, L, Bell, M, Jarvis, W. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003; 24:409414.
22.Kang, C, Kim, S, Kim, D, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004;25:860867.
23.Paramythiotou, E, Lucet, J, Timsit, J, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004;38:670677.
24.Schwaber, M, Cosgrove, S, Gold, H, Kaye, K, Carmeli, Y. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens. Emerg Infect Dis 2004;10:9499.
25.Young, LS, Perdreau-Remington, F, Winston, LG. Clinical, epidemiologic, and molecular evaluation of a clonal outbreak of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2004;38:10751083.
26.Abbo, A, Navon-Venezia, S, Hammer-Muntz, O, Krichali, T, Siegman-Igra, Y, Carmeli, Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:2229.
27.Ernst, EJ, Raley, G, Herwaldt, LA, Diekema, DJ. Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:634637.
28.Qavi, A, Segal-Maurer, S, Mariano, N, et al. Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infect Control Hosp Epidemiol 2005;26:6368.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed